Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-12-21
1995-05-30
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540495, C07D48704, A61K 3155
Patent
active
054201233
ABSTRACT:
Endothelin-inhibiting compounds of the formula ##STR1## wherein: one of R.sup.1 and R.sup.2 is Y.sup.2 -CO.sub.2 H and the other is R;
REFERENCES:
patent: 4415496 (1983-11-01), Harris et al.
patent: 4661479 (1987-04-01), Wyvratt, Jr. et al.
patent: 4724236 (1988-02-01), Eberlein et al.
patent: 5317101 (1994-05-01), Oldfield et al.
patent: 5324832 (1994-06-01), Jacobsen et al.
Derwent Abstract No. 88-289069/41 Feb. 27, 1987.
Derwent Abstract No. 88-195835/28 Nov. 26, 1986.
Derwent Abstract No. 88-061295/09 Jul. 9, 1986.
Derwent Abstract No. 87-152485/22 Oct. 11, 1985.
Derwent Abstract No. 62299 E/30 Dec. 11, 1980.
Derwent Abstract No. 40927 D/23 Sep. 11, 1979.
Derwent Abstract No. 91-254550/35 Feb. 19, 1990.
Derwent Abstract 86-246709/38 Nov. 27, 1985.
Derwent Abstract No. 35012 K/15 Sep. 24, 1981.
Allen et al., "Preparation . . . antagonists", CA116(11):106284Z, p. 778, 1992.
Bristol--Myers Squibb Company
Gaul Timothy J.
Kilcoyne John M.
Rizzo Nicholas
LandOfFree
Dibenzodiazepine endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dibenzodiazepine endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dibenzodiazepine endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-361927